Velez Juan Carlos Q, Bland Alison M, Arthur John M, Raymond John R, Janech Michael G
Department of Research, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina, USA.
Am J Physiol Renal Physiol. 2007 Jul;293(1):F398-407. doi: 10.1152/ajprenal.00050.2007. Epub 2007 Apr 11.
Intraglomerular ANG II has been linked to glomerular injury. However, little is known about the contribution of podocytes (POD) to intraglomerular ANG II homeostasis. The aim of the present study was to examine the processing of angiotensin substrates by cultured POD. Our approach was to use matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry for peptide determination from conditioned cell media and customized AQUA peptides for quantification. Immortalized mouse POD were incubated with 1-2 microM ANG I, ANG II, or the renin substrate ANG-(1-14) for different time intervals and coincubated in parallel with various inhibitors. Human mesangial cells (MES) were used as controls. POD incubated with 1 microM ANG I primarily formed ANG-(1-9) and ANG-(1-7). In contrast, MES incubated with ANG I primarily generated ANG II. In POD, ANG-(1-7) was the predominant product, and its formation was inhibited by a neprilysin inhibitor. Modest angiotensin-converting enzyme (ACE) activity was also detected in POD, although only after cells were incubated with 2 microM ANG I. In addition, we observed that POD degraded ANG II into ANG III and ANG-(1-7). An aminopeptidase A inhibitor inhibited ANG III formation, and an ACE2 inhibitor led to ANG II accumulation. Furthermore, we found that POD converted ANG-(1-14) to ANG I and ANG-(1-7). This conversion was inhibited by a renin inhibitor. These findings demonstrate that POD express a functional intrinsic renin-angiotensin system characterized by neprilysin, aminopeptidase A, ACE2, and renin activities, which predominantly lead to ANG-(1-7) and ANG-(1-9) formation, as well as ANG II degradation. These findings may reflect a specific role of POD in maintenance of intraglomerular renin-angiotensin system balance.
肾小球内的血管紧张素II(ANG II)与肾小球损伤有关。然而,关于足细胞(POD)对肾小球内ANG II稳态的贡献知之甚少。本研究的目的是检测培养的POD对血管紧张素底物的加工处理情况。我们的方法是使用基质辅助激光解吸/电离飞行时间(MALDI-TOF)质谱法测定条件细胞培养基中的肽段,并使用定制的AQUA肽进行定量分析。将永生化小鼠POD与1-2微摩尔的ANG I、ANG II或肾素底物ANG-(1-14)孵育不同时间间隔,并与各种抑制剂平行共孵育。人系膜细胞(MES)用作对照。用1微摩尔ANG I孵育的POD主要生成ANG-(1-9)和ANG-(1-7)。相比之下,用ANG I孵育的MES主要生成ANG II。在POD中,ANG-(1-7)是主要产物,其形成受到中性内肽酶抑制剂的抑制。在POD中也检测到适度的血管紧张素转换酶(ACE)活性,不过只有在细胞与2微摩尔ANG I孵育后才检测到。此外,我们观察到POD将ANG II降解为ANG III和ANG-(1-7)。氨肽酶A抑制剂抑制ANG III的形成,而ACE2抑制剂导致ANG II积累。此外,我们发现POD将ANG-(1-14)转化为ANG I和ANG-(1-7)。这种转化受到肾素抑制剂的抑制。这些发现表明,POD表达一种功能性的内在肾素-血管紧张素系统,其特征在于具有中性内肽酶、氨肽酶A、ACE2和肾素活性,主要导致ANG-(1-7)和ANG-(1-9)的形成以及ANG II的降解。这些发现可能反映了POD在维持肾小球内肾素-血管紧张素系统平衡中的特定作用。